180 related articles for article (PubMed ID: 15924146)
21. MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition.
Böttcher E; Freuer C; Steinmetzer T; Klenk HD; Garten W
Vaccine; 2009 Oct; 27(45):6324-9. PubMed ID: 19840668
[TBL] [Abstract][Full Text] [Related]
22. The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate.
Horimoto T; Takada A; Fujii K; Goto H; Hatta M; Watanabe S; Iwatsuki-Horimoto K; Ito M; Tagawa-Sakai Y; Yamada S; Ito H; Ito T; Imai M; Itamura S; Odagiri T; Tashiro M; Lim W; Guan Y; Peiris M; Kawaoka Y
Vaccine; 2006 Apr; 24(17):3669-76. PubMed ID: 16378663
[TBL] [Abstract][Full Text] [Related]
23. Plasminogen-binding activity of neuraminidase determines the pathogenicity of influenza A virus.
Goto H; Wells K; Takada A; Kawaoka Y
J Virol; 2001 Oct; 75(19):9297-301. PubMed ID: 11533192
[TBL] [Abstract][Full Text] [Related]
24. Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing.
Noble S; McLain L; Dimmock NJ
Vaccine; 2004 Aug; 22(23-24):3018-25. PubMed ID: 15297051
[TBL] [Abstract][Full Text] [Related]
25. Trends in development of the influenza vaccine with broader cross-protection.
Stropkovská A; Janulíková J; Varecková E
Acta Virol; 2010; 54(1):7-19. PubMed ID: 20201609
[TBL] [Abstract][Full Text] [Related]
26. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
[TBL] [Abstract][Full Text] [Related]
27. Live cold-adapted influenza A vaccine produced in Vero cell line.
Romanova J; Katinger D; Ferko B; Vcelar B; Sereinig S; Kuznetsov O; Stukova M; Erofeeva M; Kiselev O; Katinger H; Egorov A
Virus Res; 2004 Jul; 103(1-2):187-93. PubMed ID: 15163508
[TBL] [Abstract][Full Text] [Related]
28. Development and characterization of a live attenuated influenza B virus vaccine candidate.
Seo SU; Byun YH; Lee EY; Jung EJ; Jang YH; Kim HA; Ha SH; Lee KH; Seong BL
Vaccine; 2008 Feb; 26(7):874-81. PubMed ID: 18207290
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the reconstructed 1918 Spanish influenza pandemic virus.
Tumpey TM; Basler CF; Aguilar PV; Zeng H; Solórzano A; Swayne DE; Cox NJ; Katz JM; Taubenberger JK; Palese P; García-Sastre A
Science; 2005 Oct; 310(5745):77-80. PubMed ID: 16210530
[TBL] [Abstract][Full Text] [Related]
30. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
[TBL] [Abstract][Full Text] [Related]
31. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a virus derived from MDCK cells infected persistently with influenza A virus as a potential live-attenuated vaccine candidate in the mouse model.
Liu B; Hossain MJ; Mori I; Kimura Y
J Med Virol; 2008 May; 80(5):888-94. PubMed ID: 18360902
[TBL] [Abstract][Full Text] [Related]
33. A monoclonal antibody specific to the HA2 glycoprotein of influenza A virus hemagglutinin that inhibits its fusion activity reduces replication of the virus.
Varecková E; Wharton SA; Mucha V; Gocník M; Kostolanský F
Acta Virol; 2003; 47(4):229-36. PubMed ID: 15068378
[TBL] [Abstract][Full Text] [Related]
34. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
[TBL] [Abstract][Full Text] [Related]
35. Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice.
Qiu M; Fang F; Chen Y; Wang H; Chen Q; Chang H; Wang F; Wang H; Zhang R; Chen Z
Biochem Biophys Res Commun; 2006 May; 343(4):1124-31. PubMed ID: 16580631
[TBL] [Abstract][Full Text] [Related]
36. Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.
Talon J; Salvatore M; O'Neill RE; Nakaya Y; Zheng H; Muster T; García-Sastre A; Palese P
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4309-14. PubMed ID: 10725408
[TBL] [Abstract][Full Text] [Related]
37. Effective construction of DNA vaccines against variable influenza genes by homologous recombination.
Ljungberg K; Wahren B; Almqvist J; Hinkula J; Linde A; Winberg G
Virology; 2000 Mar; 268(2):244-50. PubMed ID: 10704333
[TBL] [Abstract][Full Text] [Related]
38. Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution.
Ghedin E; Sengamalay NA; Shumway M; Zaborsky J; Feldblyum T; Subbu V; Spiro DJ; Sitz J; Koo H; Bolotov P; Dernovoy D; Tatusova T; Bao Y; St George K; Taylor J; Lipman DJ; Fraser CM; Taubenberger JK; Salzberg SL
Nature; 2005 Oct; 437(7062):1162-6. PubMed ID: 16208317
[TBL] [Abstract][Full Text] [Related]
39. Stabilizing the glycosylation pattern of influenza B hemagglutinin following adaptation to growth in eggs.
Chen Z; Aspelund A; Jin H
Vaccine; 2008 Jan; 26(3):361-71. PubMed ID: 18079027
[TBL] [Abstract][Full Text] [Related]
40. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype.
Pavlova SP; Veits J; Mettenleiter TC; Fuchs W
Vaccine; 2009 Aug; 27(37):5085-90. PubMed ID: 19573638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
